Key result
B19-VP1u induced significant expression of MCP2, IP-10, IL-1β, IL-6, and TNF-α in H9c2 cells, whereas HBoV-VP1u only induced IL-1β and IL-6, indicating different roles in cardiac inflammation.
Why the study?
Limited information exists about the role of human bocavirus 1 in cardiac disorders compared to the known association of parvovirus B19 with cardiac inflammation.
B19-VP1u and HBoV-VP1u differentially activate inflammatory pathways in cardiomyocytes, providing insight into their respective roles in viral myocarditis and cardiac inflammation.
Answers are grounded in this paper and cite their sources.
May suggest parvovirus-specific cytokine pathways in myocarditis; leaves open translation from cell models to human disease.
Human parvovirus B19 (B19) and human bocavirus 1 (HBoV) are the only known pathogenic parvoviruses, and are responsible for a variety of diseases in human beings. Mounting evidence indicates a strong association between B19 infection and cardiac disorders including myocarditis, dilated cardiomyopathy and heart failure. However, very limited information about the role of HBoV in cardiac disorders is known. To elucidate the effects of B19 and HBoV on cardiac disorders, we expressed EGFP‑conjugate constructs of B19‑VP1 unique region (VP1u) and HBoV‑VP1u, along with the mutants EGFP‑B19‑VP1uD175A and EGFP‑HBoV‑VP1uV12A, in H9c2 cells by stable transfection. The protein expression levels of EGFP, EGFP‑B19‑VP1u, EGFP‑B19‑VP1uD175A, EGFP‑HBoV‑VP1u and EGFP‑HBoV‑VP1uV12A in H9c2 cells were observed under a fluorescence microscope and confirmed by western blotting. Secreted phospholipase A2 (sPLA2) activity was detected in B19‑VP1u and HBoV‑VP1u but not B19‑VP1uD175A and HBoV‑VP1uV12A recombinant proteins. Significantly higher expression levels of MCP2 and IP‑10 mRNA were detected in H9c2 cells that were transfected with pEGFP‑B19‑VP1u, compared with in those cells transfected with pEGFP‑HBoV‑VP1u, pEGFP‑B19‑VP1uD175A or pEGFP‑HBoV‑VP1uV12A. Significantly higher protein levels of IL‑1β and IL‑6 were detected in H9c2 cells transfected with pEGFP‑B19‑VP1u or pEGFP‑HBoV‑VP1u, compared with in those cells transfected with pEGFP‑B19‑VP1uD175A or pEGFP‑HBoV‑VP1uV12A. Notably, significantly higher expression of both TNF‑α and NF‑κB was observed only in H9c2 cells transfected with pEGFP‑B19‑VP1u, but not in those cells transfected with pEGFP‑HBoV‑VP1u, pEGFP‑B19‑VP1uD175A or pEGFP‑HBoV‑VP1uV12A. These findings, to our knowledge for the first time, reveal the difference between B19‑VP1u and HBoV‑VP1u in H9c2 cells and provide insight into the roles of B19‑VP1u and HBoV‑VP1u in the pathogenesis of cardiac inflammation.
No takes yet. Share an insight, caveat, or question.
Hii et al. (2018) studied Cardiac inflammation. B19-VP1u and HBoV-VP1u vs. pEGFP (empty vector) and mutant forms was evaluated on Expression of inflammatory chemokines and cytokines (p=<0.05). B19-VP1u induced significant expression of MCP2, IP-10, IL-1β, IL-6, and TNF-α in H9c2 cells, whereas HBoV-VP1u only induced IL-1β and IL-6, indicating different roles in cardiac inflammation.
Synapse has enriched 10 related papers. Consider them for comparative context: